Reports

Interim reports

Interim report Q3 2019 statement
Half-year Report 2019
Interim report Q1 2019 statement
Interim report Q3 2018 statement

Annual reports

Annual Report 2018
2018, First half
2017

Year-end reports

Year-end Report 2019
Year-end Report 2018

Rights issue 2019

Prospectus for Scandion Oncology

IPO 2018

Memorandum for Scandion Oncology

 

Scandion Oncology Investor Relations

Nils Brünner, CEO
E: nb@scandiononcology.com
T: +45 26144708

Investor information

Spotlight
Waterfront Building
Klarabergsviadukten 63, 9 tr
101 23 Stockholm
Sweden

Phone: +46 8 511 68 000
Website: www.spotlightstockmarket.com

Qualified Adviser

Sedermera Fondkommission
Norra Vallgatan 64
211 22 Malmö
Sweden

Phone: + 46 406151410
Website: www.sedermera.se

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union
Privacy and Cookie Policy